Outsourcing Of Clinical Research Is Booming The Outsource Blog

The clinical research outsourcing is the next big thing in Indias growth story after information technology and the industry offers tremendous potential for Kerala

Outsourcing of clinical research is booming Gulf Times The clinical research outsourcing is the next big thing in India aposs growth story after information technology and the

Blogs Twitter Feeds Outsourcing of Clinical Research Booming in India Clinical research outsourcing is the next to India shopping for clinical research outsourcing

Clinical research in India is expected to grow into a 1bn business by the end of 2010 as pharmaceutical companies in Europe and the US find it attractive to outsource clinical trials to India thanks to its large patient population,

An RNCOS sponsored report, 'Booming Clinical Trials Market in India' notes that parameters such as diverse patient pool, regulatory environment, cost, infrastructure and human resource are big drivers for this industry, although or because of It is an interesting blog. But does globalization really helps matured economy. I do not Niche outsource vendors I agree with the blogger. There is a good demand for niche outsource and BPO vendors. In my.

This has also given rise to medical tourism as another booming industry in India. India offers specialty hospitals with state of the art facilities even in smaller cities. India also offers very good educational support resulting into . With the global pharmaceutical company's preference for outsourcing to reduce costs and retain competitiveness, India is considered as a preferred destination for contract research in the pharma sector. . Search This Blog. Loading.

I reckon, locally booming economies meaning, cities and resource-extracting regions which are attracting lots of people from the countryside or upgrading rapidly from slums. We may or may not see clinical trials as part of this trend I'm not sure if IRBs have successfully clamped down on the practice, although realistically US-based pharmaceutical companies do seem to have outsourced dangerous and sometimes fatal clinical trials without sufficient ethical

However, they can now outsource to their choice of more than 500 contract research organizations CROs with wide-ranging clinical and pre-clinical capabilities. Indeed, several CROs have been a direct result of pharma downsizing, as displaced A recent study came out about CROs, indicating that business is booming, with a 12.6 compounded growth rate in the market through 2011, when it will be 29.4 billion. CROs also allow smaller biotech companies to perform drug